Dr. Lisa Swanson explores a hypothetical scenario of what might have been achievable for adult patients with atopic dermatitis if advanced systemic therapies had been initiated in early childhood, considering the potential impact on atopic progression, mental health, and bone health and growth outcomes.

This infographic summarizes guideline recommendations for treating chronic spontaneous urticaria (CSU) with antihistamines and explains how and why disease control should be assessed.
Use this educational tool to explore the daily burden of loss of smell for patients with CRSwNP.
Join Drs. Martin Metz, Moshe Ben-Shoshan, and Michelle Tarbox as they share expert insights on the burden of pediatric CSU, as well as key considerations for disease diagnosis and treatment escalation in pediatric and adult patients.
Drs Gutiérrez Junquera and Tzivinikos discuss the importance of early identification and management of pediatric EoE to improve long-term outcomes.
Experience this engaging presentation by Professors Martin Metz, Elena Netchiporouk, and Jason Hawkes to explore emerging therapies for chronic spontaneous urticaria.
Join Dr. Sarina Elmariah as she discusses the challenges in diagnosing prurigo nodularis.
Pediatric gastroenterology experts Dr Carolina Gutiérrez Junquera and Dr Christos Tzivinikos where they discuss the importance of early identification and management of pediatric EoE to improve long-term outcomes. They highlight clinical data and discuss their practical experiences with pediatric EoE, including their perspectives on co-occurring type 2 inflammatory diseases, the chronic nature of EoE, and the future of EoE research and therapeutic development.
Professors Metz, Netchiporouk, and Hawkes discuss the clinical features, pathophysiology, and therapeutic landscape of CSU, at EADV 2025.

Many AD treatment goals focus on clinical manifestations, so that if a patient is free of lesions, their disease is considered well controlled. However, the inflammatory process underlying AD reaches far beyond the skin, affecting patients in unique ways at different stages of their lives. Education on the importance of treating AD beyond the skin and altering the treatment approach to fit the individual patient will help improve clinical management and reduce long-term patient burden.
Drs Martin Metz, Moshe Ben-Shoshan, and Michelle Tarbox shared expert perspectives on chronic spontaneous urticaria (CSU) during an engaging ADVENT symposium at EADV 2026 in Vienna, Austria. The symposium explored key considerations across the CSU patient journey, from diagnosis to disease control. Key topics included the multifaceted burden of CSU on patients, caregivers, and families, practical approaches to diagnosis and assessment of disease control, and considerations for treatment escalation and advanced therapy selection in adult and pediatric patients with CSU.